Clarify Health Launches Clarify Trials
Clarify Health has announced the launch of Clarify Trials. This cloud software accelerates clinical trial recruitment within underrepresented communities and provides social determinants of health (SDoH) insights to identify research sites and investigators with the best opportunity to enroll diverse patients and assess physician referral patterns to support coordinated outreach within underserved populations.
Read more about the launch here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
January 17th 2025Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its efficacy in obesity treatment.
